GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                             Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: GRA2 is reported to act as an inverse agonist of GPR21 [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| Inhibits basal (constitutive) GPR21-mediated IP1 production in macrophages at μM concentrations [1]. | 
| Targets where the ligand is described in the comment field | |
| Target | Comment | 
| GPR21 | Positive benefit in models of diabetes/obesity [2,4] were not observed in another study [5]. A cryo-EM structure of unliganded GPR21 bound to G proteins has been reported [3]. GRA2 is reported as an inverse agonist [1]. |